Boothbay Fund Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-43,670
| Closed | -$2.97M | – | 2491 |
|
|
2022
Q3 | $2.97M | Buy |
+43,670
| New | +$2.97M | 0.07% | 338 |
|
|
2022
Q1 | – | Sell |
-18,695
| Closed | -$547K | – | 2332 |
|
|
2021
Q4 | $547K | Buy |
+18,695
| New | +$547K | 0.01% | 842 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1699 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1355 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1201 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1047 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1056 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 971 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 878 |
|
|
2019
Q2 | – | Sell |
-8,773
| Closed | -$464K | – | 861 |
|
|
2019
Q1 | $464K | Sell |
8,773
-9,280
| -51% | -$491K | 0.05% | 322 |
|
|
2018
Q4 | $741K | Buy |
+18,053
| New | +$741K | 0.11% | 150 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 876 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 831 |
|